HIV/AIDS Pneumococcal Vaccine
HIV-infected children have poorer qualitative antibody responses to PnCV
Published in AIDS Weekly, July 25th, 2005
In a recently published study, investigators in South Africa conducted a study "to determine the quantitative and qualitative antibody responses to a pneumococcal conjugate vaccine (PnCV) in human immunodeficiency virus (HIV)-exposed infected and uninfected children. Children were randomized to receive either a PnCV or placebo at 6, 10 and 14 weeks of age.
"PnCV serotype-specific antibody concentrations were measured by a standard enzyme immunoassay (EIA) and a 22F modified EIA (22F EIA) on single serum samples drawn at 21-42 days postdose 3....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-25)
More Articles from AIDS Weekly
- HIV/AIDS Drug Use
Cocaine upregulates DC-SIGN expression on dendritic cells in HIV infection - HIV/AIDS Healthcare
Satellite pharmacy at HIV clinic improves physician-pharmacist interaction - HIV/AIDS Prevention
Branded advertising campaign increases condom use in Tanzania - HIV/AIDS Viremia
Low-level viremia not uncommon during very early period of primary HIV infection - HIV/Tuberculosis Coinfection
T cell decrease in HIV/TB coinfection leads to marked cytokine reduction - Allergy and Immunology
Patients coinfected with hepatitis C and HIV mount a full response to F protein - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
